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ABSTRACT
Background. The enzymatic degradation of quorums sensing (QS) molecules (called
quorum quenching, QQ) has been considered as a promising anti-virulence therapy
to treat biofilm-related infections and combat antibiotic resistance. The recently-
discovered QQ enzymeMomL has been reported to efficiently degrade differentN -acyl
homoserine lactones (AHLs) of variousGram-negative pathogens. Herewe investigated
the effect of MomL on biofilms formed by two important nosocomial pathogens,
Pseudomonas aeruginosa and Acinetobacter baumannii.
Methods. MomL was expressed in E.coli BL21 and purified. The activity of MomL
on AHLs with hydroxyl substituent was tested. Biofilms of P. aeruginosa PAO1 and
Acinetobacter strains were formed in 96-well microtiter plates. Biofilm formation was
evaluated by crystal violet staining, plating and fluorescence microscopy. The effect of
MomL on biofilm susceptibility to antibiotics was also tested. We further evaluated
MomL in dual-species biofilms formed by P. aeruginosa and A. baumannii, and in
biofilms formed in a wound model. The effect of MomL on virulence of A. baumannii
was also tested in the Caenorhabditis elegans model.
Results. MomL reduced biofilm formation and increased biofilm susceptibility to
different antibiotics in biofilms of P. aeruginosa PAO1 and A. baumannii LMG 10531
formed in microtiter plates in vitro. However, no significant differences were detected
in the dual-species biofilm and in wound model biofilms. In addition, MomL did not
affect virulence of A. baumannii in the C. elegans model. Finally, the effect of MomL
on biofilm of Acinetobacter strains seems to be strain-dependent.
Discussion. Our results indicate that althoughMomL showed a promising anti-biofilm
effect against P. aeruginosa and A. baumanii biofilms formed in microtiter plates, the
effect on biofilm formation under conditionsmore likely tomimic the real-life situation
was much less pronounced or even absent. Our data indicate that in order to obtain
a better picture of potential applicability of QQ enzymes for the treatment of biofilm-
related infections, more elaborate model systems need to be used.
Subjects Microbiology, Infectious Diseases
Keywords Quorum quenching, Biofilm, MomL, Pseudomonas aeruginosa, Acinetobacter
baumannii, Quorum sensing inhibition, Quorum sensing
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INTRODUCTION
Quorum sensing (QS) is a widespread communication process that allows bacteria to
coordinate their group behavior based on the production, detection and response to extra-
cellular signal molecules (Bassler & Losick, 2006; Williams et al., 2007). QS regulates gene
expression related to biofilm formation, motility and production of virulence factors in
manyGram-negative andGram-positive pathogens, and interferingwithQShas been inten-
sively studied as a promising anti-virulence therapy to combat bacterial infections and an-
tibiotic resistance (Hentzer & Givskov, 2003; LaSarre & Federle, 2013; Rutherford & Bassler,
2012). Many natural and synthetic compounds have been found to inhibit QS, and several
quorum quenching (QQ) enzymes mainly targeting N -acyl homoserine lactone (AHL)
based QS in Gram-negative bacteria have been described as well (Brackman & Coenye,
2015; Fetzner, 2015; Rasmussen & Givskov, 2006; Tang & Zhang, 2014). Some of these QS
inhibitors (QSIs) and QQ enzymes have shown promising anti-virulence effects both in
vitro and in vivo. For instance, furanones which resemble AHLs and are able to bind to QS
receptors have been reported to reduce biofilm formation and enhance bacterial clearance
in Pseudomonas aeruginosa lung infection in mice (Hentzer et al., 2002; Wu et al., 2004).
Baicalin hydrate and cinnamaldehyde (QSIs targeting AHL-based QS in P. aeruginosa and
Burkholderia cepacia complex) aswell as hamamelitannin (aQSI targeting the peptide-based
QS system present in Staphylococcus aureus) increase biofilm susceptibility to antibiotics
and survival of infected Galleria mellonella larvae and Caenorhabditis elegans, as well as
decrease the microbial load in a mouse pulmonary infection model (Brackman et al., 2011).
As for QQ enzymes, an AiiM-producing P. aeruginosamutant showed reduced lung injury
and increased survival in an in vivo study on mice with pneumonia (Migiyama et al., 2013),
and an inhaled lactonase SsoPox-I was also reported to reduce virulence of P. aeruginosa
and mortality in rat pneumonia (Hraiech et al., 2014).
Previously MomL, a novel AHL lactonase belonging to the metallo-β-lactamase super-
family was identified and characterized (Tang et al., 2015). It has high degrading activities
towards short- and long-chain AHLs with or without an oxo-group at the C-3 position
(Tang et al., 2015). MomL can reduce pyocyanin and protease production by P. aeruginosa
and attenuated the virulence of P. aeruginosa in a C. elegans infection model (Tang et
al., 2015), but its effect on biofilm formation of P. aeruginosa and other Gram-negative
pathogens was not tested yet.
Besides P. aeruginosa, Acinetobacter baumannii has also been recognized as an increas-
ingly prevalent Gram-negative opportunistic pathogen responsible for severe nosocomial
infections (Gonzalez-Villoria & Valverde-Garduno, 2016; Peleg, Seifert & Paterson, 2008).
Resistance of P. aeruginosa and A. baumannii strains to multiple antibiotic classes compli-
cates the treatment for these infections and poses considerable therapeutic challengesworld-
wide (Potron, Poirel & Nordmann, 2015). One of the main factors contributing to their
reduced antibiotic susceptibility and to treatment failure is biofilm formation both on
tissues and abiotic surfaces (Donlan & Costerton, 2002;Hall-Stoodley, Costerton & Stoodley,
2004; Longo, Vuotto & Donelli, 2014). Biofilms of both P. aeruginosa and A. baumannii
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are known to be regulated by AHL-based QS. In P. aeruginosa, N -(3-oxododecanoyl)-L-
homoserine lactone (3-oxo-C12-HSL) andN -butyryl-L-homoserine lactone (C4-HSL) are
used by the Las and Rhl QS system, respectively (Pesci et al., 1997), and these AHLs can both
be degraded by MomL (Tang et al., 2015). One AHL synthase belonging to LuxI family,
AbaI, has been reported to catalyze the synthesis of N -(3-hydroxydodecanoyl)-L-HSL
(3-OH-C12-HSL) in Acinetobacter nosocomialisM2 (Niu et al., 2008), but other AHLs with
varied chain lengths and substituents are also found in Acinetobacter strains (Bhargava,
Sharma & Capalash, 2010; González et al., 2009). The biofilm-forming ability of an abaI
mutant was reduced by around 40% compared to the corresponding wildtype strain (Niu et
al., 2008). Compared to the extensive literature on inhibiting QS pathways and virulence in
P. aeruginosa (Aybey & Demirkan, 2016; Furiga et al., 2016; Hentzer et al., 2003; O’Loughlin
et al., 2013; Yin et al., 2015), there are fewer reports on inhibiting QS and biofilm formation
in A. baumannii (Bhargava et al., 2015; Chow et al., 2014; Saroj & Rather, 2013).
In the present study, we tested the anti-biofilm activity of MomL against P. aeruginosa
and A. baumannii, and further evaluated the effect of MomL under more complex
conditions such as in dual-species biofilm and in a wound model system with the aim
to obtain a better knowledge base regarding the possible development of QQ enzymes as
anti-virulence therapy.
MATERIAL & METHODS
Bacterial strains, culture conditions and chemicals
P. aeruginosa PAO1, A. calcoaceticus LMG 10517, A. nosocomialis M2 and A. baumannii
LMG10520, LMG10531 andAB5075were cultured on tryptic soy agar (TSA) or inMueller-
Hinton broth (MH) at 37 ◦C. Escherichia coli BL21(DE3) harboring MomL expression
plasmid pET24a(+)-momL-(−SP) (Tang et al., 2015) was cultured on Luria-Bertani (LB)
agar supplementedwith kanamycin (50 µg/mL) at 37 ◦C. TheAHL biosensorAgrobacterium
tumefaciens A136 (pCF218) (pCF372) (Zhu et al., 1998) was maintained on LB agar sup-
plemented with spectinomycin (50 µg/mL) and tetracycline (4.5 µg/mL), and grown in AT
minimal medium (Tempé et al., 1977) containing 0.5% (wt/vol) glucose for detecting AHLs
in the liquid X-Gal (5-bromo-4-chloro-3-indolyl- β-D-galactopyranoside) assay. 3-OH-
C12-HSL was purchased from Sigma-Aldrich and dissolved in dimethyl sulfoxide (DMSO)
as stock solution (100mM).Caenorhabditis elegansN2 (glp-4; sek-1) was propagated under
standard conditions, synchronized by hypochlorite bleaching, and cultured on nematode
growth medium using E. coli OP50 as a food source (Stiernagle, 1999).
MomL expression and purification
MomL was expressed and purified according to Tang et al. (2015). In brief, protein
expression was induced by 0.5 mM IPTG (isopropyl- β-D-thiogalactopyranoside) when
E. coli cells in LB reaching an optical density at 600 nm (OD600) of 0.5–0.7. The induction
was carried out at 16 ◦C with moderate shaking (150 rpm) for 12 h. Cells were harvested
and sonicated, and the obtained supernatant was loaded on NTA-Ni (Qiagen, Hilden,
Germany) columns for purification according to the manufacturer’s instruction. Desalting
of the protein solution was accomplished by Amicon Ultra-15 centrifugal filter devices,
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and the purified MomL was stored at −20 ◦C in Tris–HCl buffer (50 mM, pH 6.5) with
25% glycerol.
Detection for degradation of 3-OH-C12-HSL
The amount of 3-OH-C12-HSLwas quantified usingA. tumefaciensA136 liquid X-gal assay
and expressed as the normalized β-galactosidase activity as previously described (Tang et
al., 2013). The correction factor a and b were obtained and calculated for our experimental
conditions, and the final formula to calculate the normalized β-galactosidase activity is
0.716× OD492−OD620
0.205× OD620−OD492 . To test the degradation of 3-OH-C12-HSL by MomL, 3-OH-C12-HSL
(10 µM) was mixed with MomL in different concentrations (0.05–5 µg/mL) and incubated
at 37 ◦C for 1 h. No MomL was added to the control. Afterwards the residual 3-OH-C12-
HSL was quantified by adding 10 µL solution to the A136 biosensor, as described previously
(Tang et al., 2013).
Biofilm formation assays
Overnight cultures of P. aeruginosa and Acinetobacter strains in MH broth were diluted
to contain approximately 5×107 CFU/mL. 90 µL of this diluted bacterial suspension was
transferred to the wells of a round-bottomed 96-well microtiter plate. Uninoculated MH
broth served as blank control. To test the effect of MomL on biofilms, 10 µL purified
enzyme (in different concentrations) was added to the wells, while 10 µL Tris–HCl buffer
(50 mM, pH 6.5) with 25% glycerol was added to the control. The plate was incubated at
37 ◦C for 4 h before the supernatant was removed. The wells were rinsed once with sterile
physiological saline (PS) and re-filled with fresh medium (90 µL) and MomL (10 µL). The
plate was incubated at 37 ◦C for an additional 20 h. The biofilm biomass was quantified by
crystal violet (CV) staining as described previously (Peeters, Nelis & Coenye, 2008). After
rinsing the wells with sterile PS, the biofilm was fixed with 100 µL 99% methanol for 15
min and stained with 100 µL 0.1% CV for 20 min. The excess CV was removed by washing
the plates under running tap water and bound CV was released by adding 150 µl of 33%
acetic acid. The absorbance was measured at 590 nm.
Biofilm susceptibility assays
After a 24 h-biofilm of P. aeruginosa or A. baumannii strains was formed as described above
either in presence of MomL or not, the plate was emptied and biofilm cells were rinsed
with sterile PS. Antibiotics were dissolved in PS and 90 µL of these solutions were added to
treat the biofilm for another 24 h, either with or without 10 µl MomL. Tobramycin (TOB;
4 µg/mL as final concentration), ciprofloxacin (CIP; 0.5 µg/mL), meropenem (MEM; 16
µg/mL) and colistin (CST; 16 µg/mL) were used to treat the biofilm of P. aeruginosa PAO1;
TOB (6 µg/mL), CIP (4 µg/mL), MEM (8 µg/mL) and CST (16 µg/mL) were used to treat
the biofilm of the A. baumannii strains. The supernatant was removed and the wells were
washed once with sterile PS. To release bacterial cells from biofilm, two cycles of vortex
(5 min) and sonication (5 min) were performed, and the number of CFU/biofilm was
determined by plating the resulting suspensions on TSA.
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Fluorescence microscopy
Biofilms of P. aeruginosa PAO1 or A. baumannii strains were formed in the absence or
presence of MomL and treated with antibiotics as described above using a flat-bottomed
96-well microtiter plates. A total of 3 µL SYTO9 and 3 µL propidium iodide were diluted
to 1mL in sterile PS, and 100 µL of this staining solution was transferred to each well. The
plate was incubated for 15 min at room temperature and fluorescence microscopy was
performed with EVOS FL Auto Imaging System (Life Technologies, Carlsbad, CA, USA).
The red fluorescent signal was detected with 531/40 nm excitation filter cube and 593/40
nm emission filter cube and the green fluorescent signal was detected with 470/22 nm
excitation filter cube and 510/42 nm emission filter cube.
Dual-species biofilm formation
Overnight cultures of P. aeruginosa and A. baumannii strains in MH broth were diluted
to contain approximately 5×105 CFU/mL and 5×107 CFU/mL, respectively, and equal
volume of suspensions of P. aeruginosa and A. baumannii were mixed. MomL (200 µg/mL)
and tobramycin (6 µg/mL) were added as described above. To quantify CFU in the dual-
species biofilm, Pseudomonas Isolation Agar (Difco) and TSA supplemented with 5 µg/mL
cefsulodin were used as selective media for P. aeruginosa and A. baumannii respectively.
Biofilm formation in wound model
Artificial dermis composed of hyaluronic acid and collagenwas used in ourwoundmodel, as
described before (Brackman et al., 2016). Each disk of artificial dermis was placed in 24-well
microtiter plate. One mL medium containing Bolton Broth, heparinized bovine plasma
and freeze-thaw laked horse blood cells was added on and around the dermis. Suspensions
(10 µL) of P. aeruginosa or A. baumannii containing 104 bacterial cells were added on the
top of dermis. Final concentrations of MomL added were 200 µg/mL and 10 µg/mL for
P. aeruginosa and A. baumannii, respectively. Tobramycin (10 µg/mL) was added after 8
h incubation at 37 ◦C. After 24 h, the infected dermis was washed with 1 mL PS and was
transferred into 10 ml PS. Biofilm cells on the dermis were loosen and collected by three
cycles of vortex (30 s) and sonication (30 s). The number of CFU/dermis was quantified
by standard plating techniques.
C. elegans survival assay
The C. elegans survival assay was carried out as described before with minor modification
(Brackman et al., 2011). Synchronized worms (L4 stage) were suspended in medium
containing 95% M9 buffer (3 g of KH2PO4, 6 g of Na2HPO4, 5 g of NaCl, and 1 ml of
1 M MgSO4 ·7H2O in 1 l of water) and 5% brain heart infusion broth (Oxoid), and 25
µL of this nematode suspension was transferred to the wells of a 96-well microtiter plate.
Overnight culture of A. baumanniiwas suspended in the assay medium and added in a final
concentration of 2.5× 107 CFU/ml.MomLwas added in a final concentration of 10 µg/mL.
The plates were incubated at 25 ◦C for 24 h. The fraction of dead worms was determined
by counting the number of dead worms and the total number of worms in each well.
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Figure 1 SDS-PAGE of purifiedMomL. Lane1, molecular mass markers; Lane 2, purified recombinant
MomL with molecular mass of nearly 31 kDa.
Statistics
The normal distribution of the data was checked by the D’Agostino–Pearson normality
test. Normally distributed data were analyzed by one-way ANOVA, and non-normally
distributed data were analyzed by the Kruskal–Wallis test or the Mann–Whitney test. All
statistical analyses were carried out using GraphPad Prism 6.0.
RESULTS
Degradation of 3-OH-C12-HSL by purified MomL
MomL was produced in E. coli and subsequently successfully purified (Fig. 1). Although
MomL had been shown to degrade various AHLs (Tang et al., 2015), its activity on AHLs
with hydroxyl substituent at the C3 position was not tested yet. We could demonstrate that
MomL, in a concentration of 1 µg/mL or higher, can degrade almost all 3-OH-C12-HSLs
(10 µM) under the experimental conditions used in the present study (Fig. 2).
Effect of MomL on biofilm formation by P. aeruginosa and
A. baumannii
Following biofilm formation in 96-well microtiter plates and quantification by crystal
violet staining, a significant difference was observed between P. aeruginosa PAO1 control
biofilms and biofilms grown in the presence of MomL (concentration > 50 µg/mL)
(Fig. 3A). When grown with 150 µg/mL MomL, an average decrease of approximately
35% was observed. MomL inhibited A. baumannii LMG 10531 biofilm formation at
concentrations as low as 0.1 µg/mL, and the biofilm biomass was reduced by approximately
42% when exposed to 5 µg/mL MomL (Fig. 3B). No further decrease was observed when
A. baumannii LMG 10531 biofilms were grown in the presence of higher concentration of
MomL.
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Figure 2 Degradation of 3OH-C12-HSL byMomL. The amount of residual 3-OH-C12-HSL was ex-
pressed as the normalized β-galactosidase activity. Data shown are average of three technical replicates
(n= 3), error bars represent standard deviation. *, P < 0.05 when compared with non-MomL treated con-
trol (Kruskal-Wallis test).
Figure 3 Effect of MomL on biofilm formation by P. aeruginosa PAO1 (A) and A. baumannii LMG
10531 (B). Biofilms were quantified by CV staining and amount of biofilm left is expressed as CV ab-
sorbance (OD 590). Data shown are average of three biological replicates with variable numbers of techni-
cal replicates each (n≥ 27), error bars represent standard deviation. *, P < 0.05 when compared with non-
MomL treated control in Kruskal-Wallis test (A) or one-way ANOVA(B).
Effect of MomL on biofilm susceptibility to antibiotics
Application of MomL alone (200 µg/mL for P. aeruginosa PAO1 and 10 µg/mL for
A. baumannii LMG 10531) reduced the number of cultivable biofilm cells by approximately
50% in both P. aeruginosa PAO1 and A. baumannii LMG 10531. For P. aeruginosa PAO1,
combining CIP or MEM with MomL led to >70% more reduction compared to treatment
with CIP or MEM alone (Fig. 4A). For A. baumannii LMG 10531, MomL also increased
killing of biofilm cells when antibiotics were used together with MomL (Fig. 4B). In case of
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Figure 4 Effect of MomL on susceptibility of P. aeruginosa PAO1 (A) and A. baumannii LMG 10531
(B) biofilms to different antibiotics. Numbers of CFU/biofilm were determined by plating and shown as
box-whisker plots. Boxes span the interquartile range; the line within each box denotes the median, and
whiskers indicate the minimum and maximum values. MomL was added in a final concentration of 200
µg/mL for P. aeruginosa PAO1 and 10 µg/mL for A. baumannii LMG 10531. Data shown are from three
biological replicates with three technical replicates each (n = 9). Mann–Whitney tests were performed to
compare different groups (*, P < 0.05)
TOB, cell number was reduced by 80% when used in combination with MomL compared
to TOB alone. Consistent with results obtained by plating, fewer living cells were observed
in fluorescence microscope images of biofilms treated with MomL, TOB, or a combination
of both, compared to control biofilms (Fig. 5).
Effect of MomL on dual-species biofilm formed by P. aeruginosa and
A. baumannii
We also evaluated the effect of MomL on dual-species biofilm formed by P. aeruginosa
PAO1 and A. baumannii LMG 10531. We found that P. aeruginosa PAO1 inhibited growth
of A. baumannii LMG 10531 in dual-species biofilm, and most A. baumannii LMG 10531
cells were killed by P. aeruginosa PAO1 after 48 h (Fig. 6). When MomL was added, there
was a reduction in A. baumannii LMG 10531 cell numbers; however no difference was
observed in either total cell numbers or number of surviving P. aeruginosa PAO1 cells
(Fig. 6A). MomL in combination of TOB was also tested, but no change in susceptibility
to TOB was observed in the dual-species biofilm (Fig. 6B).
Effect of MomL on other Acinetobacter strains
We also tested MomL on four other Acinetobacter strains. However, only A. baumannii
LMG 10520 showed reduction in biofilm biomass when treated with MomL at 50 µg/mL
(Fig. 7). No significant difference was observed for A. calcoaceticus LMG 10517, A. nosoco-
mialisM2 andA. baumanniiAB5075. The effect ofMomL on susceptibility ofA. baumannii
LMG 10520 and A. calcoaceticus LMG 10517 biofilms was also tested. For A. baumannii
LMG 10520, significant differences were detected when MomL was added alone or in
combination with several antibiotics (Fig. 8). For A. calcoaceticus LMG 10517, no difference
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Figure 5 Representative fluorescence images of biofilms of P. aeruginosa PAO1 and A. baumannii
LMG 10531. Biofilms were treated with MomL alone, TOB alone or a combination of both and stained
with Syto9 and propidium iodide. 40× Objective (numerical aperture: 0.75) was used and the final magni-
fication is 1,200×. The scale bar represents 100 µm.
Figure 6 Effect of MomL on dual-species biofilms. Total number of CFU/biofilm, number of P. aerug-
inosa PAO1 CFU/biofilm and number of A. baumannii LMG 10531 CFU/biofilm in each dual-species
biofilm were determined by plating and shown as box-whisker plots. Boxes span the interquartile range;
the line within each box denotes the median, and whiskers indicate the minimum and maximum values.
(A). 24 h-biofilm treated with MomL alone; (B). 48 h-biofilm treated with MomL alone, TOB alone or a
combination of both. Data shown are from three biological replicates with three (A) or two (B) technical
replicates each (n= 9 for A, n= 6 for B). Mann–Whitney tests were performed to compare total, P. aerug-
inosa PAO1 and A. baumannii LMG 10531 cell numbers respectively between untreated or MomL-treated
dual-species biofilm (*, P < 0.05).
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Figure 7 Effect of MomL on biofilms formed by other Acinetobacter strains. Biofilms of A. calcoaceti-
cus LMG 10517, A. nosocomialisM2, A. baumannii LMG 10520 and A. baumannii AB5075 were treated
with different concentration of MomL and quantified by CV staining. Data shown in box-whisker plots
are from three biological replicates with variable numbers of technical replicates each (n≥ 27). Boxes span
the interquartile range; the line within each box denotes the median, and whiskers indicate the minimum
and maximum values. *, P < 0.05 when compared to untreated control (Kruskal-Wallis test).
was observed between biofilms receiving MomL treatment and biofilms receiving the
control treatment, either by plating or fluorescence microscope.
Effect of MomL in a biofilm wound model system and in the
C. elegans model
An in vitro wound model was used to mimic the conditions in an infected wound. For
both P. aeruginosa PAO1 and A. baumannii LMG 10531, MomL had no effect on biofilm
formation in this wound model (Fig. 9).
The C. elegans model was used to further evaluate whether MomL can increase survival
of nematodes infected with A. baumannii. However, no significant increase of C. elegans
survival was found after treating nematodes infected with A. baumannii LMG 10520 or
A. baumannii LMG 10531 with MomL (Fig. 10), although AHL-degrading activity was
maintained under these test conditions (Fig. S2).
DISCUSSION
QS disruption has been considered as a promising anti-infectious strategy to substitute or at
least supplement treatment with antibiotics, and could inhibit production of virulence fac-
tors and the formation of biofilms (Brackman et al., 2011). Compared to QS inhibitors, QQ
enzymes can degradeAHLs fromdifferent pathogens andmight bemore effective in treating
multispecies infections. In addition, QQ enzymes do not need to enter the cells as they
can act extracellularly, making it less likely resistance will develop (Bzdrenga et al., 2016).
The recently-discovered QQ enzyme, MomL, has strong degrading activity towards AHLs
with different acyl-chain length and substituents (oxo or hydroxyl) (Tang et al., 2015),
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Figure 8 Effect of MomL on biofilm susceptibility of A. baumannii LMG 10520 and A. calcoaceticus
LMG 10517. (A). Plating results for biofilms of A. baumannii LMG 10520 exposed to CIP, MEM, CST,
TOB alone or in combination with MomL (50 µg/mL); (B), Plating results for biofilms of A. calcoaceticus
LMG 10517 exposed to CIP, MEM, CST, TOB alone or in combination with MomL (200 µg/mL). Data
shown in box-whisker plots are from two biological replicates with three technical replicates each (n= 6).
Boxes span the interquartile range; the line within each box denotes the median, and whiskers indicate the
minimum and maximum values. Mann–Whitney tests were performed to compare control and MomL or
antibiotic treatment alone and in combination with MomL (*, P < 0.05). (C). Representative fluorescence
images of A. baumannii LMG 10520 and A. calcoaceticus LMG 10517. Biofilms were treated with MomL
alone or in combination with tobramycin and stained with Syto9 and propidium iodide. 20× Objective
(numerical aperture: 0.65) was used and the final magnification is 599×. The scale bar represents 200 µm.
and this could be an advantage when targeting bacteria like Acinetobacter strains that
produce various AHLs. MomL was reported to reduce the in vitro production of protease
and pyocyanin by P. aeruginosa and attenuate the virulence of P. aeruginosa in a C. elegans
infection model (Tang et al., 2015). The further application potential of MomL was not
determined yet. In the present study we investigated the possible use of MomL for treating
biofilm infections, and evaluate its effect on two important Gram-negative nosocomial
pathogens, P. aeruginosa and A. baumannii in different models.
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Figure 9 Effect of MomL on biofilms of P. aeruginosa PAO1 and A. baumannii LMG 10531 formed in
woundmodel. Data shown in box-whisker plots are from three biological replicates with two technical
replicates each (n = 6). Boxes span the interquartile range; the line within each box denotes the median,
and whiskers indicate the minimum and maximum values. Mann–Whitney tests were performed to com-
pare control and MomL treatment, or TOB and TOB in combination with MomL.
First we tested the effect of MomL on single-species biofilms of P. aeruginosa PAO1
and A. baumannii LMG 10531 formed in microtiter plates; a reduction of biofilm biomass
was observed for both strains. The maximum decrease in biofilm of A. baumannii LMG
10531 was achieved at a concentration of 5 µg/mL and no further decrease was observed
with higher concentrations of MomL, which indicated the presence of other mechanisms
besides QS regulating biofilm formation in A. baumannii. Higher concentrations of MomL
are needed to show an effect on biofilm of P. aeruginosa PAO1 comparing to A. baumannii
LMG 10531 (Fig. 2), possibly due to the higher concentration of AHLs produced by PAO1.
When used in combination with antibiotics, fewer biofilm cells survived compared to
antibiotic treatment alone, both for P. aeruginosa PAO1 and A. baumannii LMG 10531.
In addition, MomL showed no inhibition on planktonic cells of both P. aeruginosa and
A. baumannii (Fig. S1), and all these in vitro results seem promising and suggest possible
use of MomL to treat biofilm infections of P. aeruginosa and A. baumannii.
We subsequently investigated the effect of MomL in a dual-species biofilm formed
by P. aeruginosa and A. baumannii and in a wound biofilm model. MomL had no effect
on the overall cell number in the mixed species biofilm and the same disappointing
results were obtained in biofilms formed in wound model system. In this wound model
system, medium containing plasma, serum, horse blood and heparin were used to reflect
nutritional condition in wounds. An artificial dermis was used to mimic a wound like
surface and an inoculum of 104 cells was used to reflect the microbial load of a wound prior
to infection. Additionally, in contrast to what we observed for the mono-species biofilms
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Figure 10 Effect of MomL on the virulence of A. baumanii strains in C. elegans. Percent survival of
C. elegans infected by A. baumannii LMG 10520 and LMG 10531. Data shown in box-whisker plots are
from three biological replicates with three technical replicates each (n = 9). Boxes span the interquartile
range; the line within each box denotes the median, and whiskers indicate the minimum and maximum
values. One-way ANOVA was performed, and no significant differences were found between control and
MomL treatment in both uninfected C. elegans and those infected by A. baumannii strains.
formed in 96-well microtiter plates, MomL did not potentiate the activity of TOB in this
model system. Possible explanations for this are that component(s) present in this wound
biofilm model protect AHL from degradation and/or interfere with the activity of MomL
(potentially through interactions with proteins in the plasma), or that QS is not essential
for biofilm formation and/or resistance in these conditions. Further experiments will be
required to clarify this. Although MomL showed strong activity against 3-OH-C12-HSL
in the medium used in the C. elegans model (Fig. S2), no effect of MomL on the virulence
of A. baumanii was observed. As previously reported, an A. baumannii QS mutant did not
differ from the wild type with regards to killing in a Galleria mellonella infection model
(Peleg et al., 2009). These results indicated that although QS is known to play an important
role in A. baumanii biofilm formation, it might only have limited role in the virulence in
the C. elegans and G. mellonella models.
Thus far, a series of promising results about in vivo application of QQ enzymes have been
reported. Phosphotriesterase-like lactonase SsoPox-I has been reported to reduce biofilm
formation of P. aeruginosa at a concentration higher than 170 µg/mL, and the early use of
SsoPox-I reduced the mortality of rats with acute pneumonia from 75% to 20% (Hraiech
et al., 2014). In another study, acylase-containing coatings on silicone urinary catheters re-
duced formation of P. aeruginosa biofilms and mixed-species P. aeruginosa-E. coli biofilms
(Ivanova et al., 2015). Our data obtained in a dual-species biofilm formed by P. aeruginosa
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andA. baumannii as well as in a woundmodel strongly suggest that the effect ofMomL (and
potentially also other QQ enzymes) on in vivo grown bacterial biofilms may be much less
pronounced than the effect observed with biofilms formed under simple in vitro conditions.
Factors affecting the anti-biofilm activity in more complex systems could include stability
of the enzyme, penetration of the enzyme through the biofilm matrix, and the composition
of the environment.
Different outcomes were also observed when we evaluated the effect of MomL on dif-
ferent Acinetobacter strains, and no effects of MomL on biofilm formation was detected for
three out of fiveAcinetobacter strains tested. In addition, forA. baumaniiLMG10520, a con-
siderably higher concentration of MomL was required to obtain a pronounced inhibitory
effect than for A. baumannii LMG 10531. These results confirm that the anti-biofilm
activity of QQ enzymes is strain-dependent, which is likely to reduce their clinical efficacy.
CONCLUSION
The results of the present study highlight that there are considerable hurdles to be cleared
before QQ enzymes could potentially be used to combat infections. Our data indicate
that demonstrating AHL degrading activity in vitro and/or anti-biofilm activity in simple
in vitro biofilm model systems is not sufficient to predict an anti-biofilm effect in more
complex systems.
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